Table 2.
BMD values in different parts of the body in the three glycometabolism groups
| Group | No of patients | BMD (g/cm2)
|
||||||
|---|---|---|---|---|---|---|---|---|
| L1–4 | FN-R | FN-L | Troch-R | Troch-L | Total-R | Total-L | ||
|
| ||||||||
| Normal | 142 | 1.189±0.197 | 0.866±0.148 | 0.876±0.138 | 0.803±0.132 | 0.817±0.129 | 0.955±0.149 | 0.964±0.144 |
| IGR | 245 | 1.214±0.221 | 0.855±0.142 | 0.859±0.140 | 0.793±0.136 | 0.806±0.138 | 0.948±0.151 | 0.956±0.152 |
| T2DM | 388 | 1.204±0.185 | 0.884±0.155 | 0.879±0.124 | 0.815±0.118 | 0.823±0.122 | 0.976±0.127 | 0.979±0.132 |
| P-value adjusted for age and BMI | 0.61 | 0.59 | 0.54 | 0.39 | 0.76 | 0.19 | 0.46 | |
| P-value adjusted for age, | 0.22 | 0.53 | 0.64 | 0.63 | 0.35 | 0.87 | 0.88 | |
| BMI, height, and weight | ||||||||
Notes: Data are expressed as mean ± SD. Spearman’s rho was used to detect the relationship between abnormal glycometabolism and OP and osteopenia detection rates. Abbreviations: BMD, bone mineral density; BMI, body mass index; FN, femoral neck; IGR, impaired glucose regulation; L, left; L1–4, lumbar vertebrae 1–4; OP, osteoporosis; R, right; T2DM, type 2 diabetes mellitus; Troch, trochanter.